Vaccines, blood, antisera, toxins and cultures in   El Salvador

Exports In 2023, El Salvador exported $931k in Vaccines, blood, antisera, toxins and cultures, making it the 104th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 281st most exported product in El Salvador. The main destination of Vaccines, blood, antisera, toxins and cultures exports from El Salvador are: Bolivia ($386k), Guatemala ($249k), Nicaragua ($170k), United States ($56.4k), and Cambodia ($44.9k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of El Salvador between 2022 and 2023 were Bolivia ($386k), Guatemala ($236k), and Cambodia ($11.6k).

Imports In 2023, El Salvador imported $55.1M in Vaccines, blood, antisera, toxins and cultures, becoming the 114th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 59th most imported product in El Salvador. El Salvador imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($12.4M), Belgium ($7.08M), Germany ($6.34M), France ($4.21M), and South Korea ($4.17M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for El Salvador between 2022 and 2023 were United States ($5.22M), Netherlands ($3.14M), and Belgium ($2.79M).